1. Is the whole larger than the sum of the parts? Integrated PET/MRI as a tool for response prediction

   • Felix M. Mottaghy

   Editorial Commentary 26 December 2017 Pages: 325 - 327

2. Integrated ¹⁸F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy

   • Nariya Cho
   • Seock-Ah Im
   • Koung Jin Suh

   Original Article 04 November 2017 Pages: 328 - 339

   

3. Simultaneous whole-body ¹⁸F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study

   • Martin T. Freitag
   • Claudia Kesch
   • Frederik Giesel

   Original Article 16 October 2017 Pages: 340 - 347

   

4. Prognostic value of 18F–choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

   • Paola Caroli
   • Ugo De Giorgi
   • Federica Matteucci

   Original Article 06 November 2017 Pages: 348 - 354

5. Prospective evaluation of ¹⁸F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)

   • Ivan Jambor
   • Anna Kuisma
   • Heikki Minn

   Original Article 16 November 2017 Pages: 355 - 364

   

6. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer

   • Pierre Lovinfosse
   • Marc Polus
   • Roland Hustinx

   Original Article 18 October 2017 Pages: 365 - 375

   

7. Absolute number of new lesions on ¹⁸F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

   • Hoda Anwar
   • Christos Sachpekidis
   • Antonia Dimitrakopoulou-Strauss

   Original Article 10 November 2017 Pages: 376 - 383

   

8. ¹⁸F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment

   • Pil Soo Sung
   • Hye Lim Park
   • Si Hyun Bae

   Original Article 10 November 2017 Pages: 384 - 391

   

9. Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma

   • Xavier Palard
   • Julien Edeline
   • Etienne Garin

   Original Article Open access 25 November 2017 Pages: 392 - 401

   

10. Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue

    • Jennifer E. Gains
    • Neil J. Sebire
    • Mark N. Gaze

    Original Article 17 October 2017 Pages: 402 - 411

    

11. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems

    • Andres Kaalep
    • Terez Sera
    • Ronald Boellaard

    Original Article Open access 01 December 2017 Pages: 412 - 422

    

12. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease

    • Han Soo Yoo
    • Seok Jong Chung
    • Phil Hyu Lee

    Original Article 26 October 2017 Pages: 423 - 431

    

13. Head to head comparison of [¹⁸F] AV-1451 and [¹⁸F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia

    • Young Kyoung Jang
    • Chul Hyoung Lyoo
    • Sang Won Seo

    Original Article 16 November 2017 Pages: 432 - 442

    

14. Static and dynamic ¹⁸F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status

    • Antoine Verger
    • Gabriele Stoffels
    • Norbert Galldiks

    Original Article 17 October 2017 Pages: 443 - 451

    

15. Visualization of multiple organ amyloid involvement in systemic amyloidosis using ¹¹C-PiB PET imaging

    • Naoki Ezawa
    • Nagaaki Katoh
    • Yoshiki Sekijima

    Original Article 10 September 2017 Pages: 452 - 461

    

16. Clinical utility of FDG PET/CT in acute complicated pyelonephritis—results from an observational study

    • Chih-Hsing Wan
    • Jing-Ren Tseng
    • Tzu-Chen Yen

    Original Article 26 September 2017 Pages: 462 - 470

    

17. Current status of theranostics in prostate cancer

    • Irene Virgolini
    • Clemens Decristoforo
    • Christian Uprimny

    Review Article Open access 28 December 2017 Pages: 471 - 495

    

18. Third-line treatment and ¹⁷⁷Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

    • Finn Edler von Eyben
    • Giandomenico Roviello
    • Timo Joensuu

    Review Article Open access 16 December 2017 Pages: 496 - 508

    

19. Incidental identification of osteoid osteoma by ⁶⁸Ga-PSMA PET/CT

    • Angelo Castello
    • Egesta Lopci

    Image of the Month 15 December 2017 Pages: 509 - 510

    

20. Striking lack of visualization of striatum on ¹⁸F-FDG brain PET in chorea-acanthocytosis

    • Diego Alfonso López-Mora
    • Valle Camacho
    • Ignasi Carrió

    Image of the Month 15 December 2017 Pages: 511 - 512

    

21. ¹⁷⁷Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

    • Kambiz Rahbar
    • Hojjat Ahmadzadehfar
    • Martin Boegemann

    Letter to the Editor 21 November 2017 Pages: 513 - 514

    

22. Reply to ‘Single high dose versus repeated bone-targeted radionuclide therapy’

    • Ana M. Denis-Bacelar
    • Sarah J. Chittenden
    • Glenn D. Flux

    Editorial Commentary 15 December 2017 Pages: 515 - 517

23. Founder of EJNM passed away

    • Wolfram H. Knapp

    Obituary 05 December 2017 Pages: 518 - 519